{"entity":{"type":"insider","cik":"0001688865","url":"/insider/0001688865","json_url":"/insider/0001688865.json","name":"Alenson Carman","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2018-01-26","last":"2021-06-23","span_basis":"filed_date"},"name_variants":[{"name":"Alenson Carman","source":"filing","n_filings":12,"first_seen":"2018-01-26","last_seen":"2021-06-23"}],"transactions":[{"id":4355232,"accession":"0001439222-21-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000060","line_url":"/filing/0001439222-21-000060#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1777.0,"shares_display":"1,777","price_per_share":61.61,"price_display":"61.61","price_state":"stated","total_value":109480.97,"total_display":"109,480.97","total_whole":"109,481","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":5103875,"accession":"0001439222-21-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-21-000035","line_url":"/filing/0001439222-21-000035#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1118.0,"shares_display":"1,118","price_per_share":55.89,"price_display":"55.89","price_state":"stated","total_value":62485.02,"total_display":"62,485.02","total_whole":"62,485","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-16","filed_date":"2021-04-20","scope":"insider"},{"id":4231333,"accession":"0001439222-21-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-21-000034","line_url":"/filing/0001439222-21-000034#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":991.0,"shares_display":"991","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":53514.0,"total_display":"53,514.00","total_whole":"53,514","shares_owned_after":1118.0,"shares_owned_after_display":"1,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":2907571,"accession":"0001439222-20-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-20-000061","line_url":"/filing/0001439222-20-000061#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":39.93,"price_display":"39.93","price_state":"stated","total_value":9982.5,"total_display":"9,982.50","total_whole":"9,983","shares_owned_after":184.0,"shares_owned_after_display":"184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-04","scope":"insider"},{"id":2126575,"accession":"0001439222-20-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-20-000027","line_url":"/filing/0001439222-20-000027#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":47.3,"price_display":"47.30","price_state":"stated","total_value":16318.5,"total_display":"16,318.50","total_whole":"16,319","shares_owned_after":184.0,"shares_owned_after_display":"184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2156084,"accession":"0001439222-20-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-20-000025","line_url":"/filing/0001439222-20-000025#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":47.12,"price_display":"47.12","price_state":"stated","total_value":22240.64,"total_display":"22,240.64","total_whole":"22,241","shares_owned_after":184.0,"shares_owned_after_display":"184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":3142404,"accession":"0001439222-20-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-20-000020","line_url":"/filing/0001439222-20-000020#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2427.0,"shares_display":"2,427","price_per_share":53.37,"price_display":"53.37","price_state":"stated","total_value":129528.99,"total_display":"129,528.99","total_whole":"129,529","shares_owned_after":184.0,"shares_owned_after_display":"184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-24","scope":"insider"},{"id":8746167,"accession":"0001439222-19-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-19-000030","line_url":"/filing/0001439222-19-000030#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2950.0,"shares_display":"2,950","price_per_share":50.09,"price_display":"50.09","price_state":"stated","total_value":147765.5,"total_display":"147,765.50","total_whole":"147,766","shares_owned_after":184.0,"shares_owned_after_display":"184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-30","scope":"insider"},{"id":7866269,"accession":"0001209191-19-011483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-011483","line_url":"/filing/0001209191-19-011483#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152.0,"shares_display":"152","price_per_share":76.45,"price_display":"76.45","price_state":"stated","total_value":11620.4,"total_display":"11,620.40","total_whole":"11,620","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2019-02-20","scope":"insider"},{"id":6727026,"accession":"0001209191-18-050050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050050","line_url":"/filing/0001209191-18-050050#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":312.0,"shares_display":"312","price_per_share":83.0,"price_display":"83.00","price_state":"stated","total_value":25896.0,"total_display":"25,896.00","total_whole":"25,896","shares_owned_after":152.0,"shares_owned_after_display":"152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider"},{"id":6825158,"accession":"0001209191-18-042326","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-042326","line_url":"/filing/0001209191-18-042326#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":84.94,"price_display":"84.94","price_state":"stated","total_value":23103.68,"total_display":"23,103.68","total_whole":"23,104","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-11","scope":"insider"},{"id":6232426,"accession":"0001209191-18-005587","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005587","line_url":"/filing/0001209191-18-005587#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001688865","owner_name":"Alenson Carman","owner_display_name":"Alenson Carman","owner_url":"/insider/0001688865","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2150.0,"shares_display":"2,150","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":161250.0,"total_display":"161,250.00","total_whole":"161,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-12","filed_date":"2018-01-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Principal Accounting Officer)","n_filings":12,"first_seen":"2018-01-26","last_seen":"2021-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688865","retrieved_at":"2026-08-25T22:13:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}